BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37628981)

  • 1. Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review.
    Valvano M; Fabiani S; Monaco S; Calabrò M; Mancusi A; Frassino S; Rolandi C; Mosca M; Faenza S; Sgamma E; Cesaro N; Latella G
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients.
    Hollon JR; Cureton PA; Martin ML; Puppa EL; Fasano A
    BMC Gastroenterol; 2013 Feb; 13():40. PubMed ID: 23448408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional Consideration in Celiac Disease and Nonceliac Gluten Sensitivity.
    Naik RD; Seidner DL; Adams DW
    Gastroenterol Clin North Am; 2018 Mar; 47(1):139-154. PubMed ID: 29413009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
    Green PHR; Paski S; Ko CW; Rubio-Tapia A
    Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Nondietary Therapies for Celiac Disease.
    Alhassan E; Yadav A; Kelly CP; Mukherjee R
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):335-345. PubMed ID: 31146067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease: Hope for new treatments beyond a gluten-free diet.
    D'heedene M; Vanuytsel T; Wauters L
    Clin Nutr; 2024 Jun; 43(6):1240-1249. PubMed ID: 38648685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of celiac disease in daily clinical practice.
    Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
    Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification and management of refractory coeliac disease.
    Rubio-Tapia A; Murray JA
    Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic approach to celiac disease: a comprehensive review for primary providers.
    Cortés P; Harris DM; Bi Y
    Rom J Intern Med; 2022 Jun; 60(2):93-102. PubMed ID: 35092656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiac disease: understanding the gluten-free diet.
    Bascuñán KA; Vespa MC; Araya M
    Eur J Nutr; 2017 Mar; 56(2):449-459. PubMed ID: 27334430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac disease: advances in treatment via gluten modification.
    Stoven S; Murray JA; Marietta E
    Clin Gastroenterol Hepatol; 2012 Aug; 10(8):859-62. PubMed ID: 22728383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and novel therapeutic strategies in celiac disease.
    Kurada S; Yadav A; Leffler DA
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1211-23. PubMed ID: 27322016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
    Gross S; Bakker SF; van Bodegraven AA; van Hoogstraten IM; Gelderman KA; Bouma G; Mulder CJ; von Blomberg BM; Bontkes HJ
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):127-33. PubMed ID: 24949603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory celiac disease: from bench to bedside.
    Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
    Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
    Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
    Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
    Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
    Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional Considerations in Celiac Disease and Non-Celiac Gluten/Wheat Sensitivity.
    Abdi F; Zuberi S; Blom JJ; Armstrong D; Pinto-Sanchez MI
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.